1. RNA methyltransferase NSUN2 promotes growth of hepatocellular carcinoma cells by regulating fizzy-related-1 in vitro and in vivo.
- Author
-
Zhai CT, Tian YC, Tang ZX, and Shao LJ
- Subjects
- Animals, Apoptosis genetics, Carcinoma, Hepatocellular metabolism, Carcinoma, Hepatocellular pathology, Cdh1 Proteins metabolism, Cell Line, Tumor, Cell Movement, Cell Proliferation, Gene Expression Regulation, Neoplastic, Humans, Liver Neoplasms metabolism, Liver Neoplasms pathology, Methyltransferases antagonists & inhibitors, Methyltransferases metabolism, Mice, Inbred BALB C, Mice, Nude, Neoplasm Invasiveness, RNA, Small Interfering genetics, RNA, Small Interfering metabolism, Signal Transduction, Tumor Burden, Xenograft Model Antitumor Assays, Mice, Carcinoma, Hepatocellular genetics, Cdh1 Proteins genetics, Liver Neoplasms genetics, Methyltransferases genetics
- Abstract
The aim of the study was to investigate the role of NSUN2 (NOP2/Sun RNA Methyltransferase Family Member 2) in hepatocellular carcinoma (HCC). The expressions of NSUN2 and FZR1 were measured. Cell viability, proliferation, and apoptosis were assessed. HCC xenograft in nude mouse model was established. Tumor weight and volume were examined. Tumor tissues were collected for immunohistochemistry (IHC). TCGA database analysis and clinical sample testing suggested that the transcript levels of NSUN2 and FZR1 were increased in HCC tissues. NSUN2 knockdown inhibited HCC cell viability and proliferation, and promoted cell apoptosis. Moreover, the effects of NSUN2 could be countered by overexpressing FZR1. In animal experiment, NSUN2 silencing suppressed tumor growth in nude mice by downregulating FZR1. In conclusion, NSUN2 has a regulatory effect on HCC cell proliferation and apoptosis. NSUN2 knockout could inhibit cellular processes in HCC and tumor growth, likely via FZR1 inhibition. This finding has not only revealed the role of NSUN2 in HCC growth, but also suggests a promising target for HCC treatment., (© 2021 The Authors. The Kaohsiung Journal of Medical Sciences published by John Wiley & Sons Australia, Ltd on behalf of Kaohsiung Medical University.)
- Published
- 2021
- Full Text
- View/download PDF